Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cencora, Inc. (“Cencora” or “the Company”) (NYSE: COR). Investors who purchased Cencora securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether Cencora has violated federal securities laws.

Cencora Investigation Details

On May 6, 2026, Cencora released its second quarter 2026 financial results, including revenue of $78.3 billion, missing consensus estimates by $2.68 billion, and reducing full year 2026 revenue growth guidance to 4% to 6% (from 7% to 9%). In the accompanying earnings call, management revealed, among other things, that “manufactured list price reductions . . . represented a $2 billion revenue headwind in the quarter.” Following this news, Cencora’s stock price fell $53.16 per share, or 17.4%, to close at $252.74 per share on May 6, 2026.

What’s Next for Cencora Investors?

If you are aware of any facts relating to this investigation or purchased Cencora securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911